President Trump has made government efficiency a top priority. These efforts include eliminating improper payments and ensuring that only those who are eligible for government programs receive the benefits, including Medicaid. As President Trump said on “Meet the Press” on Sunday, May 4, 2025, “if illegal immigrants are in the mix, if people that aren’t […]
Implementation of Drug Pricing EO Should Protect Innovation and IP
President Trump’s EO addresses the dual objectives of lowering drug prices while promoting innovation and protecting IP
340B Must Be Reformed in the 119th Congress
340B reform should not only should be acted on by Congress, but also reviewed by DOGE.
Hospitals Abuse 340B Program at the Expense of Vulnerable Patients
The 340B Drug Pricing Program allows hospitals to prioritize profits over patients.
New State Report Details Costs and Abuses of the 340B Drug Pricing Program
Minnesota Department of Health 340B report is the first at the state level to show costs and abuses of the program.
340B Drug Discount Program is a Nightmare
Like many other well-intended programs 340B has ended up both wasting money and failing to provide benefits for patients.
The Case for 340B Reform Is Made on Capitol Hill
At a Capitol Hill briefing on the urgent need for reforms to the 340B Drug Pricing Program, the case was made for prompt action to fix the program. The event took place at the Senate Visitors Center on September 23, 2024, and was hosted by the Council for Citizens Against Government Waste (CCAGW). The panel […]
The 340B Drug Discount Program Needs an Overhaul
CAGW has long been concerned with the misuse of the 340B Program.
New Study Exposes More Exploitation and Waste in the 340B Drug Discount Program
A new study, “The 340B Drug Discount Program Exceeds $100B in 2022,” shows the program is misused.
New Study Confirms 340B Program is Exploited
A new study, “340B and Health Equity: A Missed Opportunity in Medically Underserved Areas,” shows the program is misused.








